Arrowhead Pharmaceuticals prices upsize convertible notes offering to $625M and stock offering at $64.50 Jan 8, 2026
Abivax is the top performing biotechnology stock YTD Dec 22, 2025 Comments Eoneren/E+ via Getty Images The S&P healthcare index (XLV) saw moderate gains in 2025,...
